MSMadhankumar Sathyamoorthy

Madhankumar Sathyamoorthy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Madhankumar Sathyamoorthy has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Jerrold Lerman

    Department of Anesthesiology John R. Oishei Children's Hospital Buffalo New York USA

    2 shared publications
  • Alan D. Penman

    1 shared publication
  • Alan Penman

    Center of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, MS, USA

    1 shared publication
  • Benjamin Walker

    Department of Anesthesiology University of Wisconsin School of Medicine and Public Health American Family Children's Hospital Madison Wisconsin 53792 USA

    1 shared publication
  • Brittany Adamiak

    Department of Dentistry, Pediatric Dentistry, University of Mississippi Medical Center, Jackson, Mississippi

    1 shared publication
  • Cayce Wallace

    Department of Dentistry, Pediatric Dentistry, University of Mississippi Medical Center, Jackson, Mississippi

    1 shared publication

Latest Publications

  • Pre‐medication before dental procedures: A randomized controlled study comparing intranasal dexmedetomidine with oral midazolam

    by Madhankumar Sathyamoorthy, Thomas B. Hamilton, Gerri Wilson, Rajesh Talluri, Lubna Fawad, Brittany Adamiak, Cayce Wallace, Irina Borissova, Christopher Heard

    Background: This study aimed to determine if intranasal dexmedetomidine is a superior pre‐medication to oral midazolam in older, difficult children.Methods: This was conducted as a prospective, single‐blind randomized control trial in a tertiary care center. Seventy‐five children, age >5 years and weight >20 kg, who needed general anesthesia for dental procedures were randomly assigned to be pre‐medicated with either oral midazolam at a dose of 0.5 mg/kg (max 15 mg) or intranasal dexmedetomidine at a dose of 2 mcg/kg (max 100 mcg). The primary outcome studied was the patients' level of sedation when separated from their parents, which was assessed using a 5‐point University of Michigan Sedation Scale. Secondary outcome studied was the level of anxiolysis assessed by the acceptance of mask induction using a 4‐point scale. All assessments were made by one research person blinded to the study drug.Results: The two groups were similar in age, sex, weight, pre‐anesthetic behavior, time from pre‐medication to anesthesia induction, and surgical time. A significantly higher proportion of patients who received dexmedetomidine had satisfactory sedation at separation from parents (69.4% vs 40.5%, P = .03) compared to those who received midazolam. There were no significant differences in the rate of acceptance of mask induction (80.6% vs 78.4%, P = 1.00). Intranasal dexmedetomidine was tolerated well when administered using a mucosal atomizer and without any clinically significant effect on heart rate or systolic blood pressure.Conclusions: Intranasal dexmedetomidine provides higher success rate in sedation and parental separation compared to oral midazolam, in older, difficult children.


  • Who Needs a Pediatric Intensive Care Unit After Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis?

    by Lawrence L. Haber, Erika D. Womack, Madhankumar Sathyamoorthy, James A. Moss, Michael Wade Shrader

    Hypotensive events (HEs) following posterior spinal fusion (PSF) for adolescent idiopathic scoliosis (AIS) can lead to delayed neurologic postoperative deficits (DNPD). This study aimed to determine the incidence of HEs (mean arterial pressure [MAP] <60 mmHg) after PSF for AIS and identify predictors for HEs. Medical records of 99 consecutive patients who had PSF for AIS were retrospectively reviewed (2011-2013). Perioperative data were collected. Patients were divided into two groups based on MAP readings by an arterial line in the pediatric intensive care unit immediately postoperatively into postoperative day one: Group 1 (MAP ≥60 mmHg) and Group 2 (multiple occurrences of MAPs <60 mmHg). Mean values were compared using the independent t test. Multiple logistic regression was used to estimate the association of preoperative and intraoperative parameters with multiple HEs. Group 1 had 68 patients (68.7%) and Group 2 had 31 patients (31.3%). None of the compared parameters were associated significantly with multiple HE. However, patients who did not exhibit HEs within the first four hours postoperatively remained stable throughout the rest of the postoperative period. Only those with HEs in the first four hours experienced subsequent HEs in the first 24 hours. There were no DNPD or other major complications. Results showed that the incidence of HEs after PSF in AIS can be as high as 31.3%. We did not find any significant risk factors. Although DNPD after PSF is a rare complication and we had none in this series, we suggest that these patients with multiple HEs may be at risk for DNPD as a result of hypotension and potential for cord ischemia. Therefore, all patients after PSF should be monitored in a pediatric intensive care unit-type environment or postanesthesia recovery room initially. If stable for, at least, the initial four hours, then patients should be good candidates for a less intensive environment. Level 3.


  • Open Access

    Spinal epidural hematoma following a thoracic epidural in a child with sickle cell disease

    by Madhankumar Sathyamoorthy, Benjamin Walker, Melissa M. Rhodes, Ike Eriator

    Key Clinical Message: Acute liver dysfunction in the perioperative period may increase the risk of epidural hematoma in a patient with a neuraxial catheter. Coagulation testing needs to be carefully monitored in these patients. An epidural hematoma should be ruled out urgently by CT or MRI in cases of a persistent motor block.


  • Stridor in Neonates After Using the Microcuff® and Uncuffed Tracheal Tubes

    by Madhankumar Sathyamoorthy, Jerrold Lerman, Rajeshri Asariparampil, Alan D. Penman, Satyan Lakshminrusimha

    Y 2011 and June 2012 were included. Data were collected from the neonatal intensive care unit database and from the electronic anesthesia record. Extracted data included postmenstrual age (PMA) at birth, birth weight, TT size and type, duration of tracheal intubation, and number of reintubations. The use of racemic epinephrine, heliox, and/or dexamethasone postextubation was considered diagnostic of stridor. RESULTS: Of the 324 neonates whose data were reviewed, 27 (8.3%) developed postextubation stridor. Neonates who developed stridor were more premature (PMA at birth, 29.9 ± 5.8 vs 33.0 ± 4.8 weeks, P = 0.001), had a lower birth weight (1.56 ± 1.07 vs 2.02 ± 0.96 kg, P = 0.005), greater duration of intubation (median: 20 vs 3 days, P < 0.0001), and multiple reintubations (median: 2 vs 0, P < 0.0001). The frequency of stridor was 17.2% after using Microcuff TT and 7.5% after using uncuffed TTs (Fisher exact test, 2-sided P = 0.08 [95% confidence interval for difference in proportions: −9.4% to 28.7%]). In a multivariable logistic regression model, after adjusting for PMA, birth weight, duration of intubation, and number of reintubations, the use of a Microcuff TT was associated with increased odds of stridor (adjusted odds ratio = 9.27 [95% confidence interval: 1.88–45.67], P = 0.006). CONCLUSIONS: The use of the Microcuff TT is associated with increased odds of postextubation stridor in neonates compared with the use of uncuffed TT....